Equity (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Jul. 26, 2021	Dec. 31, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Number of shares available for future grants		16,618,266
Common stock, Authorized		500,000,000	500,000,000
Common stock, par value		$ 0.00001	$ 0.00001
Common stock, shares Issued		87,352,364	87,352,364
Common stock, shares outstanding		87,352,364	87,352,364
Number of new shares issued		0	0
Unrecognized compensation cost		$ 1,382,997
Option term		4 years 6 months 14 days
Number of option forfeiture and cancellation		2,805,571	37,500
Share based compensation expense		$ 1,314,705
Recognized expenses		$ 1,141,542
Consulting Agreement [Member] | Justin Frere [Member] | Common Stock [Member]
Class of Stock [Line Items]
Number of shares purchase	50,000
Common stock exercise price	$ 1.72
Option term	10 years
Plan 2013 [Member]
Class of Stock [Line Items]
Stock options grant description		The 2013 Plan is administered by the Board or a committee designated by the Board. Subject to the provisions of the 2013 Plan, the Board has the authority to determine the officers, employees and consultants to whom options will be granted, the number of shares covered by each option, vesting rights and the terms and conditions of each option that is granted to them; however, no person may be granted options to purchase more than 2,000,000 shares in any one fiscal year under the 2013 Plan, and the aggregate fair market value (determined at the time the option is granted) of the shares with respect to which incentive stock options are exercisable for the first time by an optionee during any calendar year cannot exceed $100,000. Options granted pursuant to the 2013 Plan are exercisable no later than ten years after the date of grant.
Excecise price per share limit		not be less than 110% of the fair market value.
2013 Plan [Member]
Class of Stock [Line Items]
Common shares reserved for issuance		20,000,000